A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells
2007

SRC and STAT3 Activate HGF in Breast Cancer Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Sam Michelle R, Elliott Bruce E, Mueller Christopher R

Primary Institution: Queen's University

Hypothesis

Does the combination of activated Src and Stat3 transactivate the HGF promoter in human breast cancer cells?

Conclusion

The study found that activated Src and Stat3 together significantly enhance HGF transcription in human breast cells, suggesting a unique mechanism in breast cancer.

Supporting Evidence

  • Human breast cell lines showed strong transactivation of HGF by Src and Stat3.
  • The Stat3 binding site at nt-95 is crucial for HGF promoter activation.
  • Increased Src and Stat3 activity is linked to breast cancer progression.

Takeaway

This study shows that two proteins, Src and Stat3, work together to help a growth factor called HGF turn on in breast cancer cells, which might help the cancer grow.

Methodology

The researchers used co-transfection of a mouse HGF promoter construct into various human and mouse epithelial cell lines to assess HGF promoter activity.

Limitations

The study primarily focused on breast cancer cells and may not generalize to other types of cancer.

Participant Demographics

The study examined various human breast cell lines, including malignant and non-tumorigenic types.

Statistical Information

P-Value

p=0.0005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-6-69

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication